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Abstract 48 
INTRODUCTION: Patients with rheumatoid arthritis (RA) present higher incidence 49 
and severity of periodontitis than the general population. Our study, Outcomes of 50 
Periodontal Treatment in Patients with Rheumatoid Arthritis (OPERA) was a 51 
randomized waiting-list-controlled trial using mixed methods. Patients randomized 52 
to the intervention arm received intensive periodontal treatment and those in the 53 
control arm received the same treatment with a six months delay. 54 
AIM: The nested qualitative component aimed to explore patient’s experiences and 55 
priorities concerning oral health and barriers and facilitators for trial participation. 56 
METHODS: Using purposive sampling until thematic saturation was reached, we 57 
conducted 21 one-to-one semi-structured interviews with randomized patients in 58 
either of the two treatment arms as well as with patients who did not consent for 59 
trial participation. 60 
RESULTS: The patients described their experiences about RA, oral health and 61 
study participation. Previous experiences with dental care professionals shaped 62 
patients’ current perceptions about oral health and the place of oral health on their 63 
list of priorities when compared with other conditions. Patients also highlighted 64 
some of the barriers and facilitators for study participation and for compliance with 65 
oral health maintenance. The patients, in the control arm, presented their views 66 
regarding the acceptable length of waiting time for the intervention. CONCLUSION: 67 
The associations between periodontal and systemic health are increasingly 68 
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recognised by the literature. Our study provided an insight into RA patients’ 69 
experiences and perceptions about oral health. It also highlighted some of the 70 
barriers and facilitators for participating in a periodontal interventional study for this 71 
group. We hope that our findings will support the design of larger interventional 72 
periodontal studies in patients with rheumatoid arthritis. The complex challenges 73 
faced by the burden of RA and the associated multimorbidities in this patient group 74 
might highlight opportunities to improve access to oral health services in this 75 
patient population.  76 
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INTRODUCTION 77 
Chronic periodontitis is a very common chronic inflammatory condition. It affects 78 
nearly half of the UK adult population and over 60% of the elderly (Chapple 2014; 79 
White et al. 2012). Several observational studies have reported an association 80 
between chronic periodontitis and rheumatoid arthritis (RA) and chronic 81 
periodontitis has been suggested as a potential risk factor for RA (de Pablo et al. 82 
2009; Konig et al. 2016; Mikuls et al. 2009; Okada et al. 2013; Ribeiro et al. 2005). 83 
Given the high prevalence of chronic periodontitis, this association could have 84 
significant clinical and public health implications.  85 
The first symptoms of RA are noticed usually between the age of 35 and 50 and it 86 
affects mostly women. Within 5 years of diagnosis, 40% of patients reduce their 87 
working week from full time to part time, with an increase to 50% at 10 years from 88 
the first diagnosis (Mathers and Pfleger 2006). Rheumatoid arthritis affects 89 
patients’ personal and professional relationships transforming their daily routines 90 
and quality of life. Often they have to change their working circumstances or retire 91 
early, adapt their living conditions, rely on help from external sources (family, 92 
friends or social workers) and increase their feeling of vulnerability which is added 93 
as a psychological burden to their condition (Lapsley 2002).  94 
Besides the direct impact of RA on patients’ quality of life, it is important to 95 
consider also the indirect impact caused by the comorbidities secondary to RA and 96 
the side effects of the long-term use of polypharmacy in this patient group.  97 
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RA has been frequently associated with other conditions including depression, 98 
elevated blood pressure, cardiovascular disease and respiratory conditions. 99 
(Dougados et al. 2014).  100 
There are several potential mechanisms linking RA and periodontal disease. Some 101 
studies have suggested that bacteraemia caused by periodontal pathogens could 102 
be an etiological agent for RA progression (Martinez-Martinez et al. 2009). 103 
Another widely supported model relates to an aberrant immune response to 104 
periodontal pathogens in certain susceptible individuals.  One of the main 105 
periodontal pathogens is Porphyromonas gingivalis. With the recent recognition of 106 
the importance of anti-citrullinated protein antibodies (ACPA) in RA and the 107 
discovery that P. gingivalis expresses peptidyl arginine deiminase which is 108 
responsible for the post-translational citrullination of peptide antigens on arginine 109 
residues (Rosenstein et al. 2004), there is potential evidence to support a plausible 110 
pathobiologic mechanism by which periodontitis may cause or sustain the ACPA 111 
response in RA.  112 
Recent studies have also demonstrated that the uncitrullinated peptides play a 113 
major role in the antibody response for periodontitis resulting in a systemic spread 114 
of citrullinated epitopes in the presymptomatic phase of RA. Autoantigens modified 115 
by citrullination through exposure to periodontal pathogens might sustain synovial 116 
inflammation in the context of untreated periodontitis (Lopez-Oliva et al. 2018; 117 
Rosenstein et al. 2004). Antibodies for uncitrullinated RA autoantigens precede the 118 
ACPA formation and facilitate the loss of tolerance to uncitrullinated peptides (de 119 
Pablo et al. 2013).  120 
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Treatment of chronic periodontitis involves control of the dental biofilm, typically 121 
using non-pharmacological means. Whether or not such treatment can reduce the 122 
incidence and severity of RA is unknown. However, a small number of 123 
interventional studies have reported encouraging results in terms of reduced RA 124 
disease activity following periodontal treatment (Al-Katma et al. 2007; Okada et al. 125 
2011; Ortiz et al. 2009). 126 
Our trial, Outcomes of Periodontal Treatment in Patients with Rheumatoid Arthritis 127 
– OPERA, was a randomized waiting list controlled feasibility study. This trial 128 
provides feasibility data for a larger, multi-centre randomized controlled trial, which 129 
would investigate the efficacy of non-surgical periodontal treatment in reducing 130 
disease activity in patients with RA. 131 
Our trial focussed on issues of recruitment and retention, acceptability and 132 
feasibility of the trial procedures including the intervention, assessments and data 133 
collection, using a mixed methods approach. The quantitative component of our 134 
trial gathered pilot clinical data about the efficacy of periodontal treatment in 135 
patients with RA and subsequently its influence on health-related quality of life.  136 
Considering the severe burden that RA can have on the patient’s quality of life, 137 
both directly and through the comorbidities associated with this condition, it is 138 
important to gain a better understanding of patients’ priorities with regards to 139 
accessing different types of health care services. Additionally, it is important to 140 
ensure that the design of any interventional studies would take this into account 141 
and patients’ trial participation would not create an additional burden on their 142 
quality of life. As successful periodontal treatment is heavily dependent on 143 
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compliance and adherence and the treatment and trial participation both require 144 
multiple visits to the secondary care setting where this treatment was being 145 
delivered we considered important to explore the barriers and facilitators for study 146 
participation in this patient group.   147 
Furthermore, in order to encourage recruitment and retention rates in the trial, it is 148 
important to consider that outcomes that are relevant for clinicians and researchers 149 
might be less relevant for the patients. This could be especially the case for RA 150 
patients with multimorbidities as suggested in the literature (Cohen et al. 2004; 151 
Fleischmann et al. 2016). Understanding the health care priorities of this specific 152 
patient population and the place of oral health on their list of priorities was one of 153 
the most important objectives of the qualitative component of our study.  154 
Our study used a mixed method approach with a quantitative and a nested 155 
qualitative component. The quantitative aspects of the trial will be presented in 156 
detail in a separate paper. This paper focuses on the nested qualitative component 157 
of this study. 158 
Aims and objectives 159 
The aim of the qualitative component of our study was to evaluate patients’ 160 
experiences, values and priorities that shape their choices in accessing oral health 161 
services and identify the barriers and facilitators for participation in a randomized 162 
controlled trial. In order to meet this aim, we developed the following objectives: 1. 163 
Understand the impact of RA on the patient’s quality of life and the place that oral 164 
health occupies on their scale of health priorities; 2. Identify barriers and facilitators 165 
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for study participation; 3. Understand RA patients’ views about randomisation to 166 
the intervention or control group (delayed intervention). 167 
METHODS 168 
The OPERA trial recruited patients with RA, fulfilling the revised 1987 ACR 169 
classification criteria for RA (Aletaha et al. 2010). The recruitment sites were the 170 
outpatient rheumatology clinics of the Queen Elizabeth Hospital (QE), City Hospital 171 
and Heartlands Hospital all in Birmingham, U.K. 172 
A total of 691 RA patients were identified as potential participants from the three 173 
recruitment sites. Of these, 118 declined participation in the trial predominantly due 174 
to the severity of their comorbidities and the numerous medical appointments that 175 
they already have to attend. 176 
Of these, 296 patients consented to participate in the trial and 201 attended the 177 
periodontal screening visit at Birmingham Dental Hospital. Of these, 60 met both 178 
the RA and periodontal criteria for randomization and were allocated to either 179 
immediate intervention or waiting list control (delayed intervention) group (Figure 180 
1). The intervention consisted of non-surgical periodontal therapy delivered by a 181 
dental hygienist in two or more sessions in a secondary care setting.  182 
PLEASE INSERT FIGURE 1  183 
Study oversight  184 
Ethical approval for the OPERA trial was granted (11/WM/0235, protocol number 185 
RG_10-138 and registered via the Integrated Research Application System (IRAS) 186 
with project ID 53163.  187 
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Recruitment 188 
The recruitment for the trial started in January 2014 and data collection ended in 189 
December 2016.  Research and development (R&D) approval was obtained for all 190 
the participating sites.  191 
Some of the inclusion criteria for the periodontal screening were, among others, 192 
fulfilment of 2010 ACR/ EULAR classification criteria of RA (Aletaha et al. 2010) 193 
and stable medication. For randomization, patients had to have a disease activity 194 
score (DAS28) of at least 3.2 and generalized moderate to severe chronic 195 
periodontitis as evidenced by pocketing with clinical attachment loss (clinical 196 
attachment loss ≥ 4 mm on at least 2 non-adjacent teeth and cumulative probing 197 
depth ≥40mm). 198 
For exclusion criteria, we considered history of, or current, inflammatory joint 199 
disease other than RA (including, but not limited to, gout, reactive arthritis, psoriatic 200 
arthritis, seronegative spondyloarthropathy); any surgical procedure including 201 
bone/joint surgery/synovectomy (including joint fusion or replacement) within 12 202 
weeks prior to baseline or planned during study and periodontal treatment within 203 
12 months prior to baseline.   204 
A detailed description of the clinical methodology and findings will be reported in a 205 
separate paper.  206 
Screening 207 
Patients were approached for consent during their rheumatology follow-up 208 
appointments at the participating hospitals. After consenting, clinical rheumatologic 209 
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data were collected and a screening appointment was offered at the OPERA 210 
research clinic at Birmingham Dental Hospital. As some patients expressed an 211 
unwillingness to participate because of the logistic difficulties in getting to the 212 
Dental Hospital, further assistance was offered with transportation to these 213 
patients. Reminder letters with the appointment date and time for the Screening 214 
visit were sent out by post to each newly booked patient. One or two days before 215 
the appointment, a research nurse called the patients to remind them of their 216 
appointment.  217 
At Birmingham Dental Hospital, patients were assessed in a dedicated clinic 218 
available for OPERA trial patients. This involved general clinical examination, 219 
rheumatologic assessment including the disease activity score 28 (DAS28), full 220 
mouth probing, and biological sample collection.   221 
Randomization and follow-up 222 
If patients fulfilled the eligibility criteria for randomization and treatment, they were 223 
offered participation in the interventional phase of the study. After consenting for 224 
randomization and treatment, patients were randomly allocated to either immediate 225 
treatment or delayed treatment (waiting list control). For the patients allocated to 226 
the immediate treatment arm, three appointments were booked with a dental 227 
hygienist allocated for this project at maximum of three weeks after the Screening 228 
visit. Patients in the delayed treatment arm had one appointment with the same 229 
hygienist for instructions on oral health maintenance.  230 
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The same clinical examinations were carried out at the follow-up visits as at 231 
baseline. The patients allocated to the delayed treatment group were offered three 232 
appointments with the same dental hygienist for periodontal treatment at the end of 233 
the study. All the patients, at the end of the study received £150 to cover the 234 
possible costs regarding their commitments for study participation. Most patients 235 
who did not wish to consent for screening were offered the possibility to participate 236 
in the qualitative interview process, either face to face or over the telephone. 237 
Inviting patients who did not consent to take part in the clinical trial to participate in 238 
the qualitative interviews was particularly important to meet our aims and 239 
objectives in identifying barriers and facilitators for study participation.  240 
Sample Selection 241 
For the purposes of the qualitative component of this study, we used a purposeful 242 
sampling technique aimed to include a variety of patients and to ensure broad 243 
representation of views relevant to the various aspects of study participation. We 244 
therefore invited patients who:  245 
 Had declined to consent for the clinical intervention  246 
 Were screened but were not eligible for randomization for the clinical 247 
intervention   248 
 Were randomized to the immediate periodontal treatment group  249 
 Were randomized to the control group 250 
 Were representing gender diversity 251 
 Presented different lengths of time since diagnosis (RA) 252 
14 
One to one, semi-structured interviews were conducted with patients from all these 253 
groups until thematic saturation was reached. As new themes emerged from the 254 
discussions, the topic guide was constantly adapted and new themes were added 255 
until saturation was reached. Saturation was defined as the stage at which no new 256 
themes emerged from the interviews and the data started to become mainly 257 
repetitive. After saturation, three more interviews were conducted for quality 258 
assurance purposes. All interviews were carried out by the same researcher to 259 
ensure consistency. All interviews were recorded and fully transcribed. The first 260 
five interviews were conducted by a dentist under the supervision of an expert in 261 
qualitative research (psychologist). The interviews were conducted at Birmingham 262 
Dental Hospital, Queen Elizabeth Hospital Birmingham and over the telephone 263 
between October 2014 and January 2016 and lasted on average 30 minutes. 264 
Sixteen interviews were conducted face to face and five over the telephone. Some 265 
participants preferred to have the interview conducted over the telephone for 266 
convenience, especially those who did not wish to consent for trial participation. In 267 
relation to the other aspects of the study, the first patient was screened in February 268 
2014 and the last patient was randomized in October 2015.  269 
Topic guide  270 
The initial topic guide developed by the research team included: oral health 271 
maintenance, treatment preferences (dental and medical), access to dental care, 272 
priorities and values placed on oral health, quality of life issues, acceptability of the 273 
periodontal treatment and, if applicable, reasons for non-participation. This initial 274 
15 
topic guide was piloted with three patients who consented to participate. The 275 
piloting phase was developed and implemented by the research team to ensure 276 
methodological accuracy of the interview process. The results of these three 277 
interviews were included in the overall findings.  Based on the dynamics of the 278 
discussions and the flexible structure of the interviews, new themes emerged that 279 
were incorporated in the topic guide and added to the interviews with subsequent 280 
participants.  281 
Data analysis and validation 282 
A framework approach to data analysis was adopted in the manner suggested by 283 
Pope et al. (Pope and Mays 2006). The framework was developed using the topic 284 
guide and additional columns were added to the framework as new themes 285 
emerged from the interviews. One researcher (dentist) carried out the interviews 286 
and the analysis in order to assure consistency and robustness. The transcripts 287 
were read and analysed independently by a second researcher (psychologist) 288 
following NICE guidelines (Tan et al. 2009). The two researchers discussed and 289 
reached consensus of the findings. A third independent researcher was available 290 
to oversee the findings in case a consensus was not reached.  291 
RESULTS 292 
Patient demographics  293 
21 participants (15 females, 6 males) with a median age of 60 years were 294 
interviewed to participate in the interviews (Table 1).  295 
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RA disease duration ranged from 1 year to 60 years (median 19 years). More than 296 
half of the participants (n=13) had consented for periodontal screening in the study, 297 
while the remaining participants did not (n=8) (Table 1). 298 
Table 1 Demographic characteristics of participants in the qualitative component  299 
Pt # Gender Age Years since 
diagnosis 
Patient group 
1 F 60 19 Randomized - delayed 
2 M 86 20 Refused trial participation 
3 F 83 60 Refused trial participation 
4 F 37 9 Refused trial participation 
5 M 52 13 Randomized - delayed 
6 F 59 20 Refused trial participation 
7 F 68 22 Refused trial participation 
8 M 65 30 Randomized - delayed 
9 F 60 67 Refused trial participation 
10 F 65 6 Randomized - delayed 
11 F 55 12 Randomized - immediate 
12 F 59 2 Refused trial participation 
13 M 54 14 Refused trial participation 
14 M 64 10 Not eligible for randomization 
15 F 62 36 Randomized - delayed 
16 F 47 15 Randomized - delayed 
17 F 61 15 Randomized - delayed 
18 F 62 25 Randomized - immediate 
19 F 62 30 Randomized - delayed 
20 M 57 20 Randomized - immediate 
21 F 57 1 Randomized - immediate 
Median [IQR] 60 [57,64] 19 [12,25]  
 300 
The main emerging themes from the framework analysis are presented in Figure 2. 301 
These can be clustered into three main areas: “RA and quality of life”, “Oral health” 302 
and “The Study”.  The new topics that emerged from the discussions were related 303 
to patients’ perceptions of oral health and their previous experience with dental 304 
care professionals. Furthermore, the patients elaborated on their health priorities, 305 
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perceived barriers for study participation and potential solutions for the removal of 306 
those barriers.   307 
PLEASE INSERT FIGURE 2 308 
Rheumatoid arthritis and quality of life 309 
Discussions started with participants describing their experiences regarding the 310 
onset and subsequent history of their RA and the effect it had on their quality of 311 
life. All participants described the onset of their condition as highly distressing. 312 
“I remember going to pick my son up from school and walking up the high 313 
street and just with tears rolling down my face because I was in such pain… 314 
I had never known anything like it and then it just got worse from there… 315 
Everyday things that I would have done without blinking an eye just became 316 
totally impossible to do because I had no grip in my hands, no strength then 317 
to actually get myself up in the bed.” (P1)  318 
Each story carried a vivid and painful memory associated with anxiety and distress 319 
as patients and their families struggled to understand what was happening:  320 
"The children thought I was going to die.  I heard them talking to my wife 321 
and they said “Is dad going to die?” and I though, blimey, I must look bad, 322 
but I was so thin me bones were sticking out all over the place.” (P14) 323 
Some of the patients shared their stories about the impact that RA had on their 324 
work and socio-economic status. In some cases, this went as far as the patients 325 
having to change their living arrangements and make compromises in order to find 326 
ways to adapt to their new situation. 327 
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“I did retire early yes as a consequence and I had to give my home up 328 
because I couldn’t get up the stairs any more… So, within a very short 329 
space of time from 2010 to 2014 I retired early and I lost my home… I 330 
am living in a bungalow now, which has been adapted for my needs. I’ve 331 
got a wet room as opposed to a bathroom.” (P10) 332 
The majority of patients mentioned that they had taken early retirement or had to 333 
reduce their work schedule from full-time to part-time because of the impact of RA 334 
on their work life. Patients reported that this had a major negative impact on their 335 
socio-economic status. 336 
Besides work, RA also affected the ability of patients to enjoy their hobbies and 337 
social activities.  338 
“I used to enjoy football, fishing, things like that.  I couldn’t go fishing cos 339 
I couldn’t hold the rod any longer in that one position holding the rod.” 340 
(P20) 341 
As the discussions developed around the traumatizing experiences caused by the 342 
onset of RA, the patients started to describe also the challenges represented by 343 
several comorbidities that they had to deal with. 344 
Comorbidities and health priorities 345 
As the average age of the participants was around sixty years, comorbidities 346 
associated with RA were common. In order to gain a better insight into the reasons 347 
why they might or might not participate in the study, it was important to understand 348 
their health care priorities and the impact of their comorbidities and how they 349 
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prioritize the health care services that they are accessing.  Another factor was to 350 
understand where oral health was situated on their list of health care priorities. 351 
Although, several patients declared oral health as a priority in the beginning of the 352 
interview, as the discussions evolved and they reported on comorbidities, they 353 
presented a tendency to prioritise other comorbidities compared to oral health: 354 
“So, I have rheumatoid arthritis and I have asthma/COPD, so I have 355 
breathing problems, but again somebody is looking after me... And that is 356 
linked to what used to be a constant round of chest infections, but they now 357 
seem to have this under control and then oral health is the third most 358 
important thing in my life. “(P9) 359 
Patients’ numerous different hospital appointments represent a burden to some of 360 
the patients and the dental care occasionally tends to become less of a priority: 361 
"No, no I probably haven’t been to the dentist, it has got to be a year now, 362 
so but part of that is that I have so many appointments for different things at 363 
the moment, that unless I am reminded of an appointment, or given an 364 
appointment they tend to slip away." (P5) 365 
As most of the patients had multiple comorbidities, some of them tended to place 366 
oral health as the last one on the scale of importance. Their main priorities were 367 
systemic conditions including RA itself, cardiovascular disease, Crohn’s disease, 368 
asthma, chronic obstructive pulmonary disease (COPD), diabetes, etc. 369 
“My chest really, my chest is first then my rheumatoid. My teeth, round 370 
about third I think to be honest.” (P7) 371 
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“But the other thing to remember is for patients like me who have got 372 
rheumatoid, they’ve probably got other ongoing conditions as well.  There is 373 
so many things you have to try and focus on." (P4) 374 
In light of these, some patients reported that they would prefer to have their teeth 375 
extracted rather than have multiple appointments for conservative treatment:  376 
"If I had to have teeth out, I have to have them out and that’s the end of it.” 377 
(P4) 378 
Periodontitis and oral health 379 
Discussions focused on patients’ perceptions about oral health, their self-reported 380 
oral health status and previous experience that they had had with dental care 381 
professionals. Few participants reported having a good oral health status. Their 382 
past experiences regarding oral health care services shaped their perception 383 
regarding their current behaviour for accessing oral health services:  384 
"Then you never used to go to the dentist, they used to come around the 385 
school, this is going back a long time nineteen fifties and sixties. … And 386 
then most of the time they just pulled your teeth out.  That was, they never 387 
did any fillings or anything they just looked at your teeth and if they didn’t 388 
like the look of it, they just pulled out your teeth.” (P14) 389 
Patients acknowledged the importance of good oral health and reported making 390 
efforts to try to help their children to maintain good oral health:  391 
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“I mean my kids so soon as they were old enough, like two or three, I would 392 
take them, we would take them to a dentist just to get them used to a 393 
dentist, because I think fear of dentists...” (P14)  394 
Many patients reported that maintaining their oral hygiene was more difficult on the 395 
days with flare-ups: 396 
“If I have a bad flare-up of arthritis, I can’t … and I miss it and I am not able, 397 
I don’t have the strength to hold my electric toothbrush, because it is quite 398 
heavy” (P9) 399 
“If my shoulder hurts then it’s … it can be a bit difficult to brush.” (P13) 400 
Even holding the toothbrush could be challenging for some patients: 401 
“I could about hold it, I haven’t got many teeth left anyway. It’s my fear is 402 
dentists.” (P2) 403 
Participants mentioned the importance of developing a relationship based on trust 404 
with their dental care provider. This played an important role in their attitudes 405 
towards oral health and their behaviours in seeking oral health care services:  406 
“Well I am concerned that my dentist hasn’t done what needed to be done to 407 
save my teeth from breaking." (P13) 408 
Respondents reported being afraid of needles and consequently being afraid of 409 
dentists. Some patients stated that they would prefer to have extractions instead of 410 
restorative treatments. 411 
“I suppose out would be the best at my age I suppose out, you know.” (P2) 412 
When participants were asked about the way, they felt regarding their oral health, 413 
and how they regarded the visit to their dentist, many patients (particularly the 414 
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more elderly) reported negative attitudes. Younger patients on the other hand 415 
reported that they would prefer to keep their natural teeth and have them treated. 416 
As the discussions continued and patients described their comorbidities secondary 417 
to RA and how oral health fitted on their list of health care priorities, they also 418 
expressed their views regarding the outcomes that matter the most for them with 419 
regards to their quality of life and wellbeing. Amongst the most important health 420 
related outcomes considered by the patients were autonomy, mobility and lack of 421 
pain.  422 
One of them mentioned how she needed to plan her everyday activities depending 423 
on whether or not she had a flare-up:  424 
“You know, where before I used to think nothing of it, I would go off and do 425 
what I needed to do.  Now, I can’t do that, if I’m in pain I have think right I 426 
can only do one shop today, or I can’t walk that far today.” (P12) 427 
Other stories were similar:  428 
 “Health, mobility that’s very important to me that my feet were not as 429 
compromised as my hands.  Oh, that is very, absolutely I would tie those 430 
two together.” (P3) 431 
“The difficulty I was facing whilst I was working was the inability to hold a 432 
pen properly …. And work and a computer.  Erm, sitting down meant that 433 
my joints got really stiff, my knee joints and my back. And my feet and as a 434 
consequence mobility as I say became very bad… I couldn’t get upstairs to 435 
the upstairs offices.” (P10)  436 
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Personal mobility and the ability to keep their independence were key priorities for 437 
this patient population. This was also highlighted through the potential barriers that 438 
hindered study participation.  439 
Barriers for study participation 440 
The interviews explored the reasons why some patients would be reluctant to 441 
participate in the OPERA study to identify potential barriers that could be 442 
addressed by the research team. Several patients reported having negative 443 
experiences with dentists in the past and this discouraged them to participate in 444 
our trial –  445 
“Yeah, I, I think I woke up under the gas. And, I was there was blood all over 446 
the place and I was only about this high. At school. And I never went again. I 447 
stopped going for a long time” (P20) 448 
The location of the Dental Hospital was mentioned as a hindering factor by several 449 
patients: 450 
“That was because it was the Dental Hospital and I find it difficult to get from 451 
my part of the town to the Dental Hospital.” (P2) 452 
“It is a bit far away, you know the other side of town but they are moving to a 453 
new hospital shortly which will be more accessible, yes.” (P18) 454 
Due to classic features of RA such as mobility problems, fatigue and morning 455 
stiffness as well as logistic issues with the traffic from their homes to the location of 456 
the Dental Hospital, they found that without help, they could not attend their clinical 457 
appointments. 458 
24 
Besides the location of the Dental Hospital, patients mentioned forgetfulness and 459 
the overlap of their dental appointment with other medical appointments as being 460 
important hindering factors for study participation. 461 
Removal of barriers 462 
In order to address these, the participants were asked to suggest potential 463 
solutions for these problems. Some of the hindering factors were addressed by the 464 
research team, as described in the methodology section: patients received phone 465 
call reminders about their appointments and those patients that required 466 
assistance for getting to the Dental Hospital, received support in arranging the 467 
travel logistics around getting to their appointments.  468 
"Because as I say I wouldn’t have been able to undertake the study unless 469 
I’d have had payment for transportation." (P10) 470 
Financial incentives were set in place to compensate for the loss of time and 471 
logistics for the research and treatment visits. As all patients are unique and so is 472 
their situation and their experiences, some patients did not feel that financial 473 
incentives should encourage patients study participation:  474 
That always seems to help I did a lot of groups and the financial side of it 475 
isn’t a big thing to me.  When I did the conferences, it was all about 476 
expenses I was happy for my expenses to be paid, but a lot of the groups I 477 
also did erm, it would be like an interview, but there would be ten of us and 478 
we would sit around and the discussion would be recorded and you usually 479 
found that all those groups would be full because people were getting 480 
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financial…. they were being paid for it basically, but you would find that they 481 
were all full, all of them.” (P5) 482 
Some patients reported that they suffered from dental anxiety and indicated that 483 
the only way they would participate in the study would be if the screening and 484 
treatment would be done under general anaesthesia:  485 
“I mean I did say to my son because he keeps telling me off he says, “Mom, 486 
you really need to go and get your teeth sorted… And I said, I will go if they 487 
can put me to sleep”. If they can knock me out…. Yeah. I said that’s the only 488 
way I would have it done.” (P12)  489 
The control arm 490 
The control arm in our study received the same treatment as the intervention group 491 
but with a delay of six months. Patients had very diverse views with regards to the 492 
how long it was acceptable to delay their treatment. Some of them preferred to 493 
have no delay at all and some were happy with a delay of up to a few years.  494 
One of the patients who declined trial participation considered that treatment 495 
should be delivered immediately without any delay: 496 
“I think it should be done straightaway…I don’t think you should wait 497 
because with your mouth everything that goes in your stomach goes into 498 
your mouth so your gums are one of the main ones really aren’t they? So, I 499 
think you know, it should be earlier than six months.” (P6) 500 
26 
The majority of patients, however, felt that a delay of six months to their treatment 501 
would be acceptable whilst more than that might influence them to seek treatment 502 
elsewhere.  503 
“Oh, I think it’s six months… Six months would be alright…Well, perhaps 12 504 
months is, I’m 84 don’t forget.” (P2) 505 
This view was shared by the majority of patients: 506 
“I was hoping not to be in the delayed group, but as I am in the delayed 507 
group then I leave it to you erm to help me as best you can… I wouldn’t like 508 
the longer waiting time.” (P15) 509 
The intervention  510 
All patients who received the intervention, both in the immediate treatment group 511 
as well as in the delayed treatment group reported having a positive experience 512 
concerning to the intervention. 513 
“I’m really pleased actually that erm doing this study because erm had it not 514 
been for that, this could have gone on and on and it might have got to a 515 
really bad situation with my gums and I wouldn’t have known so I am really 516 
pleased.” (P11) 517 
They highlighted the importance of being kept informed about the progression of 518 
the study and the protocol and having pleasant interactions with the research staff 519 
Yeah, they have been good, I think the experience has been good.  You 520 
staff have been really helpful and I am aware of what is happening every 521 
time I come and see you.  The hygienist was great, she explained what she 522 
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was going to do and what she expected to do in future, so I think it has been 523 
a really good experience as well and eye opening as well. " (P5) 524 
This view was shared by all the patients who received the intervention: 525 
“She made me feel so comfortable and it’s embarrassing as well when you 526 
go to dentist... I find I get embarrassed. And because of the state of my 527 
teeth. I didn’t feel at bit like that from the moment. I met the hygienist and I 528 
felt quite confident that she was confident. She knew what she was doing. 529 
She explained everything. And she told me if anything hurt or to stop, to 530 
stop her. I just felt so comfortable with her… I would do it all over again.” 531 
(P21) 532 
Discussion  533 
Most studies investigating the associations between periodontitis and RA have 534 
used quantitative methodologies (Al-Katma et al. 2007; Pinho Mde et al. 2009; 535 
Ribeiro et al. 2005). OPERA was a mixed methods feasibility study with a nested 536 
qualitative component. We aimed to explore the acceptability of our study protocol 537 
and understand RA patients’ experiences and perspectives about accessing oral 538 
health care services. Furthermore, we gained some valuable insights into the place 539 
of oral health on their list of priorities, identified barriers and facilitators for study 540 
participation and gathered patients’ views about the intervention and about being 541 
randomized to the control arm. 542 
A large amount of the data regarding the oral health status of older people in 543 
England is generated from surveys of people living in residential and nursing care 544 
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homes. This represents only a minority of the elderly population and has led to a 545 
gap in our knowledge and understanding of the dental treatment preferences of 546 
this age group (Public Health England 2015). Some data suggests that for some of 547 
the older patients aesthetics are less of a priority and comfort and lack of pain are 548 
considered more important (Lord et al. 2015).  549 
To our knowledge, our study is the first one to look at oral health preferences in 550 
patients with rheumatoid arthritis and at barriers and facilitators for participation in 551 
a dental trial for this patient group. 552 
Our sample was diverse and we purposefully included patients from all the 553 
possible groups involved in the study: 1. Those who declined trial participation; 2. 554 
Those who were found ineligible for randomization after screening; 3. Patients who 555 
were randomized to intervention arm and 4. Patients randomized to control arm. 556 
We also aimed to include patients of both genders and with different durations of 557 
RA diagnosis.   558 
We have found that patients’ prior experiences, values and priorities tend to have a 559 
strong impact on shaping their choices for accessing different health care services. 560 
RA patients’ treatments require a holistic approach and whilst their rheumatologic 561 
care often takes into account their different systemic comorbidities, oral health is 562 
commonly missed out from this picture. Patients identified a set of barriers and 563 
facilitators that can influence their participation in an interventional study. Some of 564 
these barriers were related to patients’ limited mobility and logistic difficulties 565 
associated with getting to their dental appointments.  566 
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Our patients’ main concerns appeared to be represented by the ability to have as 567 
“normal” a life as possible - to live independently, autonomously and pain free. 568 
These findings are in line with the literature with regards to RA patients with 569 
multimorbidities and how these shape their choices and priorities in terms of 570 
accessing health care services (Malm et al. 2017; Ward et al. 2007).  571 
Our patients described their personal experiences regarding RA and the impact of 572 
this condition on their quality of life. They reported how the condition affected their 573 
physical and emotional well-being as well as the influence it had over their socio-574 
economic status as a consequence of the reduction of work and/or early retirement 575 
based on disability. 576 
Although many participants acknowledged the importance of good oral health and 577 
its potential impact on general health, when compared to RA and the other 578 
comorbidities that they have to live with, oral health was not a high priority.  579 
The patients identified a number of hindering factors that might impact on their 580 
ability for study participation and some of these factors were addressed by the 581 
research team with adaptations of the study protocol.  582 
In many cases, patients reported that they had to balance their life around the 583 
treatment they received for RA and for their comorbidities: this involved multiple 584 
medications, hospital visits, etc. The overall burden of RA and of the associated 585 
comorbidities over the quality of life of these patients could be quite overwhelming. 586 
Compliance with regular oral hygiene maintenance is key to maintaining good oral 587 
and periodontal health but it can become an extra burden for this cohort, especially 588 
on the days when they are dealing with flare-ups caused by their rheumatoid 589 
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condition. Patients who struggle with high burden of debilitating systemic 590 
multimorbidities, perhaps unsurprisingly, reported that oral health was a not key 591 
priority for them.  592 
We have also identified a number of limitations to this study. This cohort presented 593 
a median disease duration of 19 [12, 25] years. We acknowledge that the initial 594 
therapeutic options and approaches at the time of their diagnosis were quite 595 
different from those of today. Therefore, we can hypothesise that disease 596 
progression in this cohort could be significantly different compared to a cohort with 597 
a more recent onset of RA. This could potentially lead to different findings in a 598 
cohort with current early RA. When we developed the protocol for the randomized 599 
controlled trial, we aimed to include patients diagnosed with RA who were on 600 
stable treatment with disease-modifying antirheumatic drugs (DMARDs) for at least 601 
2 months in order to reduce the likelihood of potential confounding factors caused 602 
by medication changes. It is often the case for early diagnosed RA patients to 603 
change classes of drugs and dosages, therefore after discussing this issue with 604 
rheumatologists in the research team we decided that in order to meet this goal we 605 
focus the recruitment on patients with stable established RA.  606 
From a public health perspective, the burden of non-communicable diseases 607 
(NCDs) is becoming more and more pressing on the limited resources available for 608 
national health systems. It is perhaps time to consider new, creative ways of 609 
developing care packages that may include oral health care for patients with 610 
NCDs. This idea is supported by the American Diabetes Association as well as by 611 
the French National Authority for Health, which recommends the inclusion of a 612 
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comprehensive periodontal examination as part of the referrals for initial care 613 
management in diabetic patients (American Diabetes Association 2018; Haute 614 
Autorité de Santé 2014). A similar approach may have beneficial effects for 615 
patients with other NCDs such as rheumatoid arthritis, cardiovascular disease, 616 
kidney disease, etc.   617 
The nested qualitative component of the OPERA trial provided an insight into 618 
rheumatoid arthritis patients’ experiences and perceptions with regards to oral 619 
health. Our study also highlighted some of the potential barriers and facilitators for 620 
participating in a periodontal interventional study in this patient population. We 621 
hope that these findings will support the design of larger interventional periodontal 622 
studies in patients with rheumatoid arthritis. 623 
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